treatment of myelodysplastic syndromes refractory to hypomethylating agent
Published 10 years ago • 509 plays • Length 6:47Download video MP4
Download video MP3
Similar videos
-
3:46
hypomethylating agents in the treatment of high-risk mds
-
10:11
novel agents and treatment strategies in myelodysplastic syndromes
-
5:53
defining and predicting response to hypomethylating agents in myelodysplastic syndrome
-
4:03
treatment landscape for patients with myelodysplastic syndromes
-
6:01
treatment of myelodysplastic syndromes (mds)
-
3:14
advantages of chemotherapy and hypomethylating agents in myelodysplastic syndrome
-
4:16
myelodysplastic syndromes treatment: past, present and goals for the future
-
7:21
role of genetics in myelodysplastic syndromes
-
26:05
options for treatment of mds
-
4:48
hypomethylating agents in mds management
-
6:57
hypomethylating agents in mds: factors to consider
-
8:13
introduction: treatment landscape of mds
-
6:01
diagnosis of myelodysplastic syndrome
-
25:30
when is treatment needed for myelodysplastic syndrome (mds)?
-
1:13
dr. ai on the use of hypomethylating agents in patients with mds
-
9:28
options in low-risk disease mds
-
32:13
precision care for myelodysplastic syndromes
-
1:02
the stages and treatments for myelodysplastic syndromes
-
3:08
the treatment protocol for higher risk mds